Sartorius Stedim Biotech (CHIX:DIMP) Inventory Turnover: 0.59 (As of Mar. 2026)

What is Sartorius Stedim Biotech Inventory Turnover?

Sartorius Stedim Biotech CHIX:DIMP 84 Inventory Turnover is 0.59 as of Mar. 2026. GuruFocus rates CHIX:DIMP with a GF Score™ of 84/100 and a GF Value™ of €206.54 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Sartorius Stedim Biotech's Cost of Goods Sold for the three months ended in Mar. 2026 was €416 Mil. Sartorius Stedim Biotech's Average Total Inventories for the quarter that ended in Mar. 2026 was €703 Mil. Sartorius Stedim Biotech's Inventory Turnover for the quarter that ended in Mar. 2026 was 0.59.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Sartorius Stedim Biotech's Days Inventory for the three months ended in Mar. 2026 was 154.12.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Sartorius Stedim Biotech's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 0.92.

Sartorius Stedim Biotech (CHIX:DIMp) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Sartorius Stedim Biotech's Days Inventory for the three months ended in Mar. 2026 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Mar. 2026 )	/	Cost of Goods Sold (Q: Mar. 2026 )	*	Days in Period
	=	702.8	/	416.1	*	365 / 4
	=	154.12

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Sartorius Stedim Biotech's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	702.8	/	761.5
	=	0.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

Sartorius Stedim Biotech Inventory Turnover Related Terms

Sartorius Stedim Biotech Inventory Turnover Historical Data

* Premium members only.

The historical data trend for Sartorius Stedim Biotech's Inventory Turnover can be seen below:

Sartorius Stedim Biotech Inventory Turnover Chart

Sartorius Stedim Biotech Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Inventory Turnover

Get a 7-Day Free Trial

2.13

1.85

1.62

2.01

2.36

Sartorius Stedim Biotech Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Inventory Turnover	Get a 7-Day Free Trial															0.57	0.58	0.53	0.64	0.59

84GF Score

Sartorius Stedim Biotech SA CHIX:DIMP

Inventory Turnover is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Sartorius Stedim Biotech Inventory Turnover Calculation

Sartorius Stedim Biotech's Inventory Turnover for the fiscal year that ended in Dec. 2025 is calculated as

	Inventory Turnover (A: Dec. 2025 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (A: Dec. 2025 )	/ (	(Total Inventories (A: Dec. 2024 )	+	Total Inventories (A: Dec. 2025 ))	/	count )
=	1622.2	/ (	(684.9	+	690.9)	/	2 )
=	1622.2	/	687.9
=	2.36

Sartorius Stedim Biotech's Inventory Turnover for the quarter that ended in Mar. 2026 is calculated as

	Inventory Turnover (Q: Mar. 2026 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (Q: Mar. 2026 )	/ (	(Total Inventories (Q: Dec. 2025 )	+	Total Inventories (Q: Mar. 2026 ))	/	count )
=	416.1	/ (	(690.9	+	714.7)	/	2 )
=	416.1	/	702.8
=	0.59

Frequently Asked Questions Learn more about Inventory Turnover →

What does a Inventory Turnover of 0.59 mean?

Sartorius Stedim Biotech (CHIX:DIMP) has a Inventory Turnover of 0.59 as of Mar. 2026. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Sartorius Stedim Biotech and its competitors.

Is Sartorius Stedim Biotech's Inventory Turnover too high?

Sartorius Stedim Biotech's current Inventory Turnover is 0.59. Overall, Sartorius Stedim Biotech has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Sartorius Stedim Biotech's Inventory Turnover compare to ISRG and BDX?

Sartorius Stedim Biotech's Inventory Turnover of 0.59 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Inventory Turnover for a Medical Devices & Instruments company?

A good Inventory Turnover depends on the Medical Devices & Instruments industry context. However, Inventory Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Inventory Turnover mean?

A high Inventory Turnover can signal that a stock is expensive relative to its fundamentals. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Sartorius Stedim Biotech and its competitors. Sartorius Stedim Biotech's current Inventory Turnover is 0.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Sartorius Stedim Biotech stock overvalued right now?

Based on GuruFocus' analysis, Sartorius Stedim Biotech (CHIX:DIMP) is currently considered Modestly Undervalued. The stock's GF Value™ is €206.54, compared to a current price of €180.90 — trading 12.4% below its estimated fair value. The current Inventory Turnover is 0.59. Sartorius Stedim Biotech's overall GF Score™ is 84/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Inventory Turnover calculated?

Inventory Turnover is calculated from a company's financial statements. For Sartorius Stedim Biotech (CHIX:DIMP), the current Inventory Turnover is 0.59 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sartorius Stedim Biotech (CHIX:DIMP) Overvalued in 2026?

Based on GuruFocus' analysis, Sartorius Stedim Biotech stock appears to be undervalued. The current stock price of €180.90 is trading 12.4% below its estimated GF Value™ of €206.54. GuruFocus considers Sartorius Stedim Biotech to be Modestly Undervalued.

Key valuation signals for CHIX:DIMP:

Inventory Turnover: 0.59
GF Value™: €206.54 vs. price of €180.90 (12.4% below fair value)
GF Score™: 84/100 with 5 warning signs

No single metric tells the full story. See the CHIX:DIMP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sartorius Stedim Biotech Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies XPAR:ALCJ XPAR:MLBON XPAR:ALSPW XPAR:ALSAF XPAR:EL ISRG TSE:7741 BDX XSWX:ALC MDLN RMD WST XSWX:STMN TSE:4543 COO SOLV OCSE:COLO B NZSE:FPH ALGN BAX

Other Exchanges SRTOY:USA SDMHF:USA 0RG8:UK DIM:France 56S1:Germany

Address Otto-Brenner-Strasse 20, Goettingen, DEU, 37079

Website https://www.sartorius.com

Sartorius Stedim Biotech is a leading provider of bioprocessing solutions. It sells equipment and consumables for fermentation, filtration, fluid management, purification, and cell culture media for manufacturing biologic drugs and has a focus on single-use technology. It is a subsidiary of Sartorius AG, which has 71.5% ownership and 83% voting control. The business is geographically diverse, with 35% of sales from the Americas, 42% from Europe, the Middle East, and Africa, 15% from Asia excluding China, and 8% from China.

84GF Score

Get the complete analysis for CHIX:DIMP

Inventory Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€180.90

Price

€206.54

GF Value

View CHIX:DIMP Analysis

See Inventory Turnover data for all stocks →